Supplementary Methods and Materials from Genetic Variants of <i>VEGFA</i> and <i>FLT4</i> Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
Autoría
autor:
Dylan M. Glubb,
Daniel Crona,
Veli-Matti Leppänen